FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2138869304> ?p ?o ?g. }

• W2138869304 endingPage "180" @default.
• W2138869304 startingPage "173" @default.
• W2138869304 abstract "Lyso(bis)phosphatidic acid (LBPA) is a novel antigenic target in anti-phospholipid syndrome (APS) and antibodies directed against LBPA (aLBPA) have been detected in sera from APS patients. In this study we first evaluated aLBPA in comparison with the most widely used methods (i.e. anticardiolipin [(aCL)-enzyme-linked immunosorbent assay (ELISA)] and antibeta-2-glycoprotein-I antibodies (abeta(2)-GPI-ELISA) utilized to detect antiphospholipid antibodies in patients with primary or secondary APS, systemic lupus erythematosus, chronic HCV infection and healthy subjects. We then assessed the relationship between aLBPA, lupus anticoagulant (LAC) and the main clinical manifestations of APS. Finally, we evaluated the presence of 'pure' (i.e. beta(2)-GPI-independent) aLBPA in patients with APS and controls. The results indicate that aLBPA as well as abeta(2)-GPI display higher specificity but lower sensitivity for APS compared to aCL. Moreover, serum aLBPA correlate closely with aCL and abeta(2)-GPI in APS patients and are strictly associated with LAC positivity. We demonstrate that beta(2)-GPI binds to LBPA with affinity similar to CL, and antibodies able to react with phosholipid-protein complex exist; however, 'pure' aLBPA can also be detected in sera of APS patients. Altogether these data confirm that LBPA may be an antigenic target in APS and that aLBPA are serological markers of APS with similar sensitivity and specificity compared to abeta(2)-GPI. However, the clinical utility of aLBPA detection alone or in combination with aCL and/or abeta(2)-GPI remains to be elucidated in larger and longitudinal studies." @default.
• W2138869304 created "2016-06-24" @default.
• W2138869304 creator A5004485732 @default.
• W2138869304 creator A5041973290 @default.
• W2138869304 creator A5048821169 @default.
• W2138869304 creator A5050503305 @default.
• W2138869304 creator A5051526168 @default.
• W2138869304 creator A5056092156 @default.
• W2138869304 creator A5060904495 @default.
• W2138869304 creator A5064822882 @default.
• W2138869304 creator A5087114501 @default.
• W2138869304 date "2005-02-07" @default.
• W2138869304 modified "2023-10-11" @default.
• W2138869304 title "Anti-lysobisphosphatidic acid antibodies in patients with antiphospholipid syndrome and systemic lupus erythematosus" @default.
• W2138869304 cites W1495951828 @default.
• W2138869304 cites W150620516 @default.
• W2138869304 cites W1573826699 @default.
• W2138869304 cites W1596313173 @default.
• W2138869304 cites W1678247920 @default.
• W2138869304 cites W1775749144 @default.
• W2138869304 cites W1990849520 @default.
• W2138869304 cites W1991721757 @default.
• W2138869304 cites W2000383134 @default.
• W2138869304 cites W2012817138 @default.
• W2138869304 cites W2015748415 @default.
• W2138869304 cites W2041297457 @default.
• W2138869304 cites W2046147253 @default.
• W2138869304 cites W2046838002 @default.
• W2138869304 cites W2048948369 @default.
• W2138869304 cites W2058954135 @default.
• W2138869304 cites W206689509 @default.
• W2138869304 cites W2070527591 @default.
• W2138869304 cites W2070546668 @default.
• W2138869304 cites W2080975717 @default.
• W2138869304 cites W2093142543 @default.
• W2138869304 cites W2101831374 @default.
• W2138869304 cites W2113891001 @default.
• W2138869304 cites W2114637484 @default.
• W2138869304 cites W2115318470 @default.
• W2138869304 cites W2125615840 @default.
• W2138869304 cites W2126400039 @default.
• W2138869304 cites W2132343226 @default.
• W2138869304 cites W2147895511 @default.
• W2138869304 cites W2151687723 @default.
• W2138869304 cites W2152900444 @default.
• W2138869304 cites W2165779220 @default.
• W2138869304 cites W2241337454 @default.
• W2138869304 cites W2336044841 @default.
• W2138869304 cites W2405851433 @default.
• W2138869304 cites W2413614190 @default.
• W2138869304 cites W2416822367 @default.
• W2138869304 cites W2464246282 @default.
• W2138869304 cites W4245776591 @default.
• W2138869304 cites W4296981399 @default.
• W2138869304 doi "https://doi.org/10.1111/j.1365-2249.2005.02727.x" @default.
• W2138869304 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1809340" @default.
• W2138869304 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15762889" @default.
• W2138869304 hasPublicationYear "2005" @default.
• W2138869304 type Work @default.
• W2138869304 sameAs 2138869304 @default.
• W2138869304 citedByCount "34" @default.
• W2138869304 countsByYear W21388693042012 @default.
• W2138869304 countsByYear W21388693042013 @default.
• W2138869304 countsByYear W21388693042014 @default.
• W2138869304 countsByYear W21388693042015 @default.
• W2138869304 countsByYear W21388693042016 @default.
• W2138869304 countsByYear W21388693042017 @default.
• W2138869304 countsByYear W21388693042018 @default.
• W2138869304 countsByYear W21388693042019 @default.
• W2138869304 countsByYear W21388693042020 @default.
• W2138869304 countsByYear W21388693042021 @default.
• W2138869304 crossrefType "journal-article" @default.
• W2138869304 hasAuthorship W2138869304A5004485732 @default.
• W2138869304 hasAuthorship W2138869304A5041973290 @default.
• W2138869304 hasAuthorship W2138869304A5048821169 @default.
• W2138869304 hasAuthorship W2138869304A5050503305 @default.
• W2138869304 hasAuthorship W2138869304A5051526168 @default.
• W2138869304 hasAuthorship W2138869304A5056092156 @default.
• W2138869304 hasAuthorship W2138869304A5060904495 @default.
• W2138869304 hasAuthorship W2138869304A5064822882 @default.
• W2138869304 hasAuthorship W2138869304A5087114501 @default.
• W2138869304 hasBestOaLocation W21388693042 @default.
• W2138869304 hasConcept C147483822 @default.
• W2138869304 hasConcept C159654299 @default.
• W2138869304 hasConcept C195616568 @default.
• W2138869304 hasConcept C203014093 @default.
• W2138869304 hasConcept C2776874634 @default.
• W2138869304 hasConcept C2780022809 @default.
• W2138869304 hasConcept C2780648854 @default.
• W2138869304 hasConcept C45189115 @default.
• W2138869304 hasConcept C71924100 @default.
• W2138869304 hasConcept C86803240 @default.
• W2138869304 hasConceptScore W2138869304C147483822 @default.
• W2138869304 hasConceptScore W2138869304C159654299 @default.
• W2138869304 hasConceptScore W2138869304C195616568 @default.
• W2138869304 hasConceptScore W2138869304C203014093 @default.
• W2138869304 hasConceptScore W2138869304C2776874634 @default.
• W2138869304 hasConceptScore W2138869304C2780022809 @default.

• next